In 2010, the Sabin Vaccine Institute’s Human Hookworm Vaccine Initiative (HHVI) celebrated its 10-year anniversary. HHVI is the first and only product development partnership (PDP) aimed at human hookworm vaccine development.

Watch and listen as Sabin President Dr. Peter Hotez discusses the impact of hookworm infection on impoverished communities around the world, and learn why Sabin scientists are committed to developing a vaccine to prevent infection.